RTO.L

Rentokil Initial Plc
Rentokil Initial PLC - Director/PDMR Shareholding
14th March 2025, 10:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 7497A
Rentokil Initial PLC
14 March 2025
 

 

Notification of transaction by a Person Closely Associated with a Person Discharging Managerial Responsibilities

 

 

Rentokil Initial plc (the 'Company') has been notified that on 12 March 2025, the following transaction occurred by a person closely associated ('PCA') with a Person Discharging Managerial Responsibilities ('PDMR'), in respect of their purchase of American Depositary Shares ('ADS'), where each ADS represents five ordinary shares of one pence each in the capital of the Company.

 

PDMR

Number of ADSs acquired

Price

Trustees of the David John Frear Revocable Trust, a PCA of David Frear, a Non-Executive Director

1,750

USD $20.9539 per ADS

 

The notification below, which has been made in accordance with the requirements Article 19 of the UK Market Abuse Regulation, provides further detail.

 

Rachel Canham

Group General Counsel & Company Secretary 

Tel: +44 (0)1293 858000

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

Trustees of the David John Frear Revocable Trust

 

2

 

Reason for the notification

 

a)

 

Position/status

 

PCA of David Frear, a Non-Executive Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Rentokil Initial plc American Depositary Shares

 

 

CUSIP: 760125104

b)

 

Nature of the transaction

 

 

Purchase of American Depositary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

USD 20.9539

 

1,750

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Total price

 

 

 

1,750

 

USD 36,669.33

e)

 

Date of the transaction

 

2025-03-12

f)

 

Place of the transaction

 

New York Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCGDXDUBDGUS]]>
TwitterFacebookLinkedIn